Latest Articles

  • Inpatient glycemic management in noncritically ill patients: Updated guidelines
    Michelle D. Lundholm, MD and Oscar L. Morey-Vargas, MD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 615-618; DOI: https://doi.org/10.3949/ccjm.90a.23049

    The guidelines include a role for newer diabetes technologies and nontraditional insulin and noninsulin therapies.

  • In Reply: A new paradigm for adult ADHD
    Michael J. Manos, PhD and Elizabeth J. Short, PhD
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 593; DOI: https://doi.org/10.3949/ccjm.90c.10003
  • Persistent rectal pain leading to diffuse pustules
    Lydia Cassard, BA, Taylor A. Bullock, MD, Wyatt Andrasik, MD and Anthony P. Fernandez, MD, PhD
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 537-539; DOI: https://doi.org/10.3949/ccjm.90a.22089

    The authors relate the workup of a 34-year-old patient with a history of syphilis and human immunodeficiency virus.

  • Born again: The many lives of metformin
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 523-524; DOI: https://doi.org/10.3949/ccjm.90b.09023

    Repurposing old drugs for new indications is not a new drug-development strategy.

  • Cutaneous metastasis from gastric carcinoma
    Li-wen Zhang, MD, Wen-ju Wang, MD, Tao Chen, MD, PhD and Rong-hua Xu, MD
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 533-534; DOI: https://doi.org/10.3949/ccjm.90a.22085

    The patient presented with asymptomatic nodules and alopecia of the scalp 3 years after treatment for gastric adenocarcinoma.

  • When should pharmacologic therapies be used for uremic pericarditis?
    When should pharmacologic therapies be used for uremic pericarditis?
    Osamah Badwan, MD, Warren Skoza, MD, Lorenzo Braghieri, MD, Ian Persits, DO and Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 549-554; DOI: https://doi.org/10.3949/ccjm.90a.23003

    If symptoms return or fail to improve with renal replacement therapy, drug therapy may be considered.

  • Why 25-dehydroxyvitamin D is a negative acute-phase reactant
    Maria J. Antonelli, MD, Irving Kushner, MD and Murray Epstein, MD, FASN, FACP
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 535; DOI: https://doi.org/10.3949/ccjm.90c.09001
  • Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?
    Paloma Rodriguez, MD, Kevin M. Pantalone, DO, ECNU, FACE, Marcio L. Griebeler, MD and Bartolome Burguera, MD, PhD
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 545-548; DOI: https://doi.org/10.3949/ccjm.90a.22096

    The authors appraise the evidence to date for weight loss with metformin in this patient population.

  • Petaloid dermatosis affecting the scalp and genitalia
    Taylor A. Bullock, MD, Shruti Agrawal, MD and Wilma Bergfeld, MD
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 527-528; DOI: https://doi.org/10.3949/ccjm.90a.22100

    The patient had seen no improvement with a 2-week course of terbinafine cream.

  • If a patient has cirrhosis, should I correct coagulation abnormalities before a minor invasive procedure?
    Emily B. Wolf, MD, Marie Plante, MD and Razvan M. Chirila, MD
    Cleveland Clinic Journal of Medicine September 2023, 90 (9) 541-543; DOI: https://doi.org/10.3949/ccjm.90a.23005

    Hemostatic abnormalities in cirrhosis can include thrombocytopenia, prolonged prothrombin time, prolonged activated partial thromboplastin time, elevated international normalized ratio, and decreased fibrinogen.

Pages